| 149 |
Peptide Oxidation Leading to Hypertension |
Frazer Lowe |
BY-SA |
209: Peptide Oxidation
|
952: Hypertension
|
Under Development |
1.50 |
| 207 |
NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans |
Jinhee Choi |
All rights reserved |
1174: Activation, NADPH Oxidase
|
1277: Reproductive failure
|
|
|
| 213 |
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH) |
Lyle Burgoon |
Open for adoption |
1490: Inhibition, Fatty Acid Beta Oxidation
|
1489: Increase, Steatohepatitis
|
|
|
| 220 |
Cyp2E1 Activation Leading to Liver Cancer |
Francina Webster |
BY-SA |
1391: Activation of Cyp2E1
|
1395: Liver Cancer
|
WPHA/WNT Endorsed |
1.24 |
| 266 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 267 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 268 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 282 |
Adverse outcome pathway on photochemical toxicity initiated by light exposure |
Satomi Onoue |
BY-SA |
1115: Increase, Reactive oxygen species
|
1599: Inflamatory events in light-exposed tissues
|
Under Review |
1.49 |
| 298 |
Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer |
Shihori Tanabe |
BY-SA |
1115: Increase, Reactive oxygen species
|
1651: Treatment-resistant gastric cancer
|
Under Review |
1.58 |
| 324 |
Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation and cell death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 386 |
Deposition of ionizing energy leading to population decline via inhibition of photosynthesis |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 387 |
Deposition of ionising energy leading to population decline via mitochondrial dysfunction |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 396 |
Deposition of ionizing energy leads to population decline via impaired meiosis |
Erica Maremonti |
All rights reserved |
1550: Deposition of Ionizing Energy
|
3 AOs
|
|
|
| 406 |
SARS-CoV-2 infection leading to hyperinflammation |
Hasmik Yepiskoposyan |
All rights reserved |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 413 |
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure |
Carmel Mothersill |
BY-SA |
926: Oxidation, Glutathione (To be considered with MIE)
|
351: Increased Mortality
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 462 |
Activation of reactive oxygen species leading the atherosclerosis |
Hiromi Ohara |
BY-SA |
1115: Increase, Reactive oxygen species
|
None
|
|
|
| 505 |
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 507 |
Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway |
Yanhong Wei |
All rights reserved |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 511 |
The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects |
Yanhong Wei |
All rights reserved |
1115: Increase, Reactive oxygen species
|
2161: Increase, Vascular disrupting effects
|
|
|
| 513 |
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 534 |
Succinate dehydrogenase (SDH) inhibition leads to oxidative stress |
Xavier COUMOUL |
All rights reserved |
2118: Succinate dehydrogenase, inhibited
|
1392: Increase, Oxidative Stress
|
|
|
| 538 |
Adverse outcome pathway of PFAS-induced vascular disrupting effects via activating oxidative stress related pathways |
Yanhong Wei |
All rights reserved |
None
|
2161: Increase, Vascular disrupting effects
|
|
|